Drug Shortage Report for MYLAN-RILUZOLE

Last updated on 2021-02-09 History
Report ID 132026
Drug Identification Number 02390299
Brand name MYLAN-RILUZOLE
Common or Proper name RILUZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) RILUZOLE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 60BT
ATC code N07XX
ATC description OTHER NERVOUS SYSTEM DRUGS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2021-03-10
Actual start date
Estimated end date 2021-04-20
Actual end date 2021-02-08
Shortage status Avoided shortage
Updated date 2021-02-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-02-09 French Compare
v3 2021-02-09 English Compare
v2 2021-01-20 French Compare
v1 2021-01-20 English Compare

Showing 1 to 4 of 4